Mississippi Attorney General Jim Hood has filed a lawsuit against Eli Lilly and Company for claims arising from Lilly’s sale and marketing of its antipsychotic prescription drug, Zyprexa®. The suit was filed in the State Circuit Court of Lafayette County, according to State of Mississippi Special Assistant Attorney General Tim Balducci of the Langston Law Firm in Booneville, Miss.

Pharmaceutical company Eli Lilly and Co. on Friday said its second-quarter earnings rose as the company generated more revenue from newer drugs. Lilly also noted that Cymbalta, its depression treatment drug, witnessed stronger sales in the quarter....

Reuters - Eli Lilly and Co. on Friday reported strong second-quarter earnings, fueled by strong revenue growth of newer drugs, including an almost doubling of sales for its Cymbalta depression treatment.

Reuters - The U.S. Food and Drug Administration approved the drug Gemzar for treating recurrent ovarian cancer, ignoring the advice given by an FDA panel earlier this year that had strongly recommended against approval, Eli Lilly and Co., the drug maker, said Monday.

AP - Drug companies are racing to capture the ballooning market in diabetes care. Pfizer Inc. plans to debut Exubera, its new inhaled insulin treatment, in July, and Merck & Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.